A retrospective evaluation of therapeutic efficacy and safety of chemoradiotherapy in older patients (aged ≥ 75 years) with limited-disease small cell lung cancer: insights from two institutions and review of the literature

Shiono, Ayako; Imai, Hisao; Endo, Satoshi; Katayama, Kazuki; Sato, Hideaki; Hashimoto, Kosuke; Miura, Yu; Okazaki, Shohei; Abe, Takanori; Mouri, Atsuto; Kaira, Kyoichi; Masubuchi, Ken; Kobayashi, Kunihiko; Minato, Koichi; Kato, Shingo; Kagamu, Hiroshi

doi:10.2478/raon-2024-0054

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424. doi: 10.3322/caac.21492
Open DOI Search in Google Scholar Back to article
Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24: 4539–44. doi: 10.1200/JCO.2005.04.4859
Open DOI Search in Google Scholar Back to article
Dómine M, Moran T, Isla D, Martí JL, Sullivan I, Provencio M, et al. SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019). Clin Transl Oncol 2020; 22: 245–55. doi: 10.1007/s12094-020-02295-w
Open DOI Search in Google Scholar Back to article
Sekine I, Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T, Saijo N. Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials. Cancer Treat Rev 2004; 30: 359–68. doi: 10.1016/j.ctrv.2003.12.006
Open DOI Search in Google Scholar Back to article
Morita T. A statistical study of lung cancer in the annual of pathological autopsy cases in Japan, from 1958 to 1997, with reference to time trends of lung cancer in the world. Jpn J Cancer Res 2002; 93: 15–23. doi: 10.1111/j.1349-7006.2002.tb01195.x
Open DOI Search in Google Scholar Back to article
Pallis AG, Shepherd FA, Lacombe D, Gridelli C. Treatment of small-cell lung cancer in elderly patients. Cancer 2010; 116: 1192–200. doi: 10.1002/cncr.24833
Open DOI Search in Google Scholar Back to article
National Comprehensive Cancer Network clinical practice guidelines in oncology (NCCN Guidelines^®). Small cell lung cancer. [internet]. 2023. [cited 2023 Oct 9]. Available at: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1462
Search in Google Scholar Back to article
Dingemans AC, Früh M, Ardizzoni A, Besse B, Faivre-Finn C, Hendriks LE, et al. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021; 32: 839–53. doi: 10.1016/j.annonc.2021.03.207
Open DOI Search in Google Scholar Back to article
Sekine I, Fukuda H, Kunitoh H, Saijo N. Cancer chemotherapy in the elderly. Jpn J Clin Oncol 1998; 28: 463–73. doi: 10.1093/jjco/28.8.463
Open DOI Search in Google Scholar Back to article
Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004; 22: 4626–31. doi: 10.1200/JCO.2004.02.175
Open DOI Search in Google Scholar Back to article
Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002; 20: 3054–60. doi: 10.1200/JCO.2002.12.071
Open DOI Search in Google Scholar Back to article
Yuen AR, Zou G, Turrisi AT, Sause W, Komaki R, Wagner H, et al. Similar outcome of elderly patients in intergroup trial 0096. Cancer 2000; 89: 1953–60. doi: 10.1002/1097-0142(20001101)89:9<;1953::AID-CNCR11>3.3.CO;2-Y
Open DOI Search in Google Scholar Back to article
Schild SE, Stella PJ, Brooks BJ, Mandrekar S, Bonner JA, McGinnis WL, et al. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer 2005; 103: 2349–54. doi: 10.1002/cncr.21034
Open DOI Search in Google Scholar Back to article
Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706–14. doi: 10.1097/JTO.0b013e31812f3c1a
Open DOI Search in Google Scholar Back to article
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline. (version 1.1). Eur J Cancer 2009; 45: 228–47. doi: 10.1016/j.ejca.2008.10.026
Open DOI Search in Google Scholar Back to article
Gridelli C, Casaluce F, Sgambato A, Monaco F, Guida C. Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential chemoradiotherapy vs. concurrent chemoradiotherapy: that’s the question. Transl Lung Cancer Res 2016; 5: 150–4. doi: 10.21037/tlcr.2016.03.03
Open DOI Search in Google Scholar Back to article
Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study. Cancer 1998; 82: 836–41. doi: 10.1002/(sici)1097-0142(19980301)82:5<;836::aid-cncr6>3.0.co;2-h
Open DOI Search in Google Scholar Back to article
Shimizu T, Sekine I, Sumi M, Ito Y, Yamada K, Nokihara H, et al. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older. Jpn J Clin Oncol 2007; 37: 181–5. doi: 10.1093/jjco/hym005
Open DOI Search in Google Scholar Back to article
Okamoto K, Okamoto I, Takezawa K, Tachibana I, Fukuoka M, Nishimura Y, et al. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients. Jpn J Clin Oncol 2010; 40: 54–9. doi: 10.1093/jjco/hyp137
Open DOI Search in Google Scholar Back to article
Shukuya T, Takahashi T, Harada H, Ono A, Akamatsu H, Taira T, et al. Chemoradiotherapy for limited-disease small-cell lung cancer in elderly patients aged 75 years or older. Jpn J Clin Oncol 2013; 43: 176–83. doi: 10.1093/jjco/hys197
Open DOI Search in Google Scholar Back to article
Okamoto K, Okamoto I, Takeda M, Kobayashi S, Takeda K, Nakamatsu K, et al. A phase I study of split-dose cisplatin and etoposide with concurrent accelerated hyperfractionated thoracic radiotherapy in elderly patients with limited-disease small cell lung cancer. Jpn J Clin Oncol 2014; 44: 743–8. doi: 10.1093/jjco/hyu071
Open DOI Search in Google Scholar Back to article
Corso CD, Rutter CE, Park HS, Lester-Coll NH, Kim AW, Wilson LD, et al. Role of chemoradiotherapy in elderly patients with limited-stage small-cell lung cancer. J Clin Oncol 2015; 33: 4240–6. doi: 10.1200/JCO.2015.62.4270
Open DOI Search in Google Scholar Back to article
Kubo T, Fujiwara K, Hotta K, Okada T, Kuyama S, Harita S, et al. A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102. Cancer Chemother Pharmacol 2016; 78: 769–74. doi: 10.1007/s00280-016-3135-2
Open DOI Search in Google Scholar Back to article
Misumi Y, Okamoto H, Sasaki J, Masuda N, Ishii M, Shimokawa T, et al. Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604. BMC Cancer 2017; 17: 377. doi: 10.1186/s12885-017-3353-y
Open DOI Search in Google Scholar Back to article
Stinchcombe TE, Fan W, Schild SE, Vokes EE, Bogart J, Le QT, et al. A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients. Cancer 2019; 125: 382–90. doi: 10.1002/cncr.31813
Open DOI Search in Google Scholar Back to article
Christodoulou M, Blackhall F, Mistry H, Leylek A, Knegjens J, Remouchamps V, et al. Compliance and outcome of elderly patients treated in the concurrent Once-Daily versus Twice-Daily radiotherapy (CONVERT) trial. J Thorac Oncol 2019; 14: 63–71. doi: 10.1016/j.jtho.2018.09.027
Open DOI Search in Google Scholar Back to article
Killingberg KT, Grønberg BH, Slaaen M, Kirkevold Ø, Halvorsen TO. Treatment outcomes of older participants in a randomized trial comparing two schedules of twice-daily thoracic radiotherapy in limited-stage SCLC. J Thorac Oncol 2023; 18: 803–12. doi: 10.1016/j.jtho.2023.01.012
Open DOI Search in Google Scholar Back to article
Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, et al. Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2015; 33: 3199–212. doi:10.1200/JCO.2015.62.3488
Open DOI Search in Google Scholar Back to article
Crawford J, Caserta C, Roila F, Group EGW. Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications. Ann Oncol 2010; 21(Suppl 5): v248–51. doi: 10.1093/annonc/mdq195
Open DOI Search in Google Scholar Back to article
Fujiwara T, Kenmotsu H, Naito T, Kawamura T, Mamesaya N, Kotake M, et al. The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum. Cancer Chemother Pharmacol 2017; 79: 1229–37. doi: 10.1007/s00280-017-3324-7
Open DOI Search in Google Scholar Back to article
Kies MS, Mira JG, Crowley JJ, Chen TT, Pazdur R, Grozea PN, et al. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study. J Clin Oncol 1987; 5: 592–600. doi: 10.1200/JCO.1987.5.4.592
Open DOI Search in Google Scholar Back to article
Oshita F, Kurata T, Kasai T, Fakuda M, Yamamoto N, Ohe Y, et al. Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions. Jpn J Cancer Res 1995; 86: 1198–202. doi: 10.1111/j.1349-7006.1995.tb03315.x
Open DOI Search in Google Scholar Back to article
Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012; 30: 1692–8. doi: 10.1200/JCO.2011.40.4905
Open DOI Search in Google Scholar Back to article
Jara C, Gómez-Aldaraví JL, Tirado R, Meseguer VA, Alonso C, Fernández A. Small-cell lung cancer in the elderly--is age of patient a relevant factor? Acta Oncol 1999; 38: 781–6. doi: 10.1080/028418699432941
Open DOI Search in Google Scholar Back to article
Kasahara N, Imai H, Kaira K, Mori K, Wakuda K, Ono A, et al. Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy. Radiol Oncol 2015; 49: 409–15. doi: 10.1515/raon-2015-0037
Open DOI Search in Google Scholar Back to article

A retrospective evaluation of therapeutic efficacy and safety of chemoradiotherapy in older patients (aged ≥ 75 years) with limited-disease small cell lung cancer: insights from two institutions and review of the literature

References

Paradigm

My account